Patrick W Smith
CIK 1167028 · CHIEF EXECUTIVE OFFICER · last filed 2026-09-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AXON price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 2-411
SCOTTSDALE, AZ 85259
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXON | CHIEF EXECUTIVE OFFICER | 3,119,242 | $313.97 | $979.35M | -$632.72M | 48 | 2026-09-10 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 2,872,671 | $3.20 | $9.19M | $2.45M | 5 | 2025-02-11 |
| AXON ENTERPRISE, INC. (AAXN) Delisted | CHIEF EXECUTIVE OFFICER | 370,310 | — | — | -$67.10M | 21 | 2020-12-23 |
Recent Filings · Page 5 of 14
132 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-01 | AXON | Notice (144) | −47,314 | -$18.91M | EDGAR |
| 2024-09-30 | AXON | Notice (144) | −4,746 | -$1.88M | EDGAR |
| 2024-09-04 | AXON | Notice (144) | −2,539 | -$901.8K | EDGAR |
| 2024-09-04 | AXON | Mixed | −539 | $415.3K | EDGAR |
| 2024-08-30 | AXON | Notice (144) | −168,000 | -$60.82M | EDGAR |
| 2024-08-27 | AXON | Mixed | −300 | $565.8K | EDGAR |
| 2024-08-23 | AXON | Notice (144) | −170,300 | -$63.47M | EDGAR |
| 2023-12-20 | AXON | Gift (G) | −60,000 | $0 | EDGAR |
| 2023-05-30 | AXON | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | AXON | Mixed | +6 | -$807 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.